Concepedia

Author

Saskia C. van der Boor

Program for Appropriate Technology in Health

Also Known As

Saskia C van der Boor, Saskia C. van der Boor

9

Publications

152

Citations

5

H-Index

0

Concepts

All Affiliations

Program for Appropriate Technology in HealthImperial College LondonRadboud University NijmegenRadboud University Medical CenterRadboud Institute for Molecular Life Sciences
SC

About

Saskia C. van der Boor is an author at Program for Appropriate Technology in Health.

Saskia C. van der Boor

×

3

Publications

133

Citations

3

H-Index

YearCitations

A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1

Meta Roestenberg, Jona Walk, Saskia C. van der Boor,

Science Translational Medicine

2020

81

Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults

Saskia C. van der Boor, Merel Smit, Stijn W. van Beek,

The Lancet Infectious Diseases

2022

41

Modeling the Impact of a Highly Potent <i>Plasmodium falciparum</i> Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria Transmission

Joseph D. Challenger, Stijn W. van Beek, Rob ter Heine,

The Journal of Infectious Diseases

2023

11

Page 1